Skip to content

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.

by Jose R Pineda, Raúl Pardo, Diana Zala, Hua Yu, Sandrine Humbert, Frédéric Saudou
Molecular brain ()
Get full text at journal

Abstract

Huntington's disease (HD) is an inherited neurogenerative disease caused by an abnormal expansion of glutamine repeats in the huntingtin protein. There is currently no treatment to prevent the neurodegeneration caused by this devastating disorder. Huntingtin has been shown to be a positive regulator of vesicular transport, particularly for neurotrophins such as brain-derived neurotrophic factor (BDNF). This function is lost in patients with HD, resulting in a decrease in neurotrophic support and subsequent neuronal death. One promising line of treatment is therefore the restoration of huntingtin function in BDNF transport.

Cite this document (BETA)

Authors on Mendeley

Readership Statistics

39 Readers on Mendeley
by Discipline
 
82% Agricultural and Biological Sciences
 
10% Medicine and Dentistry
 
3% Physics and Astronomy
by Academic Status
 
36% Student > Ph. D. Student
 
33% Researcher
 
18% Student > Master
by Country
 
15% France
 
5% United Kingdom
 
3% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in